Honliv Healthcare advances probe, control review in push to resume HK tradingTip Ranks·Oct 2, 2026 at 09:42 AM099060.00%
Honliv Healthcare details July timetable for probes and audits in Hong Kong resumption pushTip Ranks·Jul 6, 2026 at 02:07 PM099060.00%
Honliv expects RMB 63 million loan forensic probe to wrap around July 19, 2026, as trading suspension continuesPUBT·Jul 6, 2026 at 01:58 PM099060.00%
Honliv Healthcare Extends Trading Suspension Amid Delay in FY2025 Audited ResultsTip Ranks·Mar 25, 2026 at 04:08 AM099060.00%
Honliv Healthcare Faces Auditor Exit and Probe Over Unrecorded RMB63 Million LoanTip Ranks·Mar 24, 2026 at 11:40 PM099060.00%
Honliv Healthcare Requests Trading Halt Pending Further AnnouncementTip Ranks·Mar 20, 2026 at 04:08 AM099060.00%
"Performance" HONLIV HEALTH turned a profit into a loss of 673,000 RMB in half a yearAASTOCKS·Sep 1, 2025 at 02:26 AM099060.00%
HONLIV HEALTH released its interim results, with a loss attributable to shareholders of RMB 673,000, turning from profit to loss year-on-yearZhitong·Aug 29, 2025 at 02:38 PM099060.00%
"Profit Warning" HONLIV HEALTH forecasts a loss of no more than 2 million RMB in the first half of the yearAASTOCKS·Aug 17, 2025 at 02:00 PM099060.00%
HONLIV HEALTH issued a profit warning, expecting a mid-term net loss attributable to shareholders of no more than 2 million yuan, a year-on-year loss compared to profitZhitong·Aug 15, 2025 at 02:58 PM099060.00%
HONLIV HEALTH announced its 2024 performance, with profit attributable to owners of the company at 31.151 million yuan, a year-on-year decrease of 18.7%Zhitong·Mar 28, 2025 at 04:20 PM099060.00%
On February 7th, HONLIV HEALTH spent HKD 6.3092 million to repurchase 2.962 million sharesZhitong·Feb 7, 2025 at 11:19 AM099060.00%
On February 4th, HONLIV HEALTH spent HKD 6.2923 million to repurchase 3 million sharesZhitong·Feb 4, 2025 at 10:37 AM099060.00%
On February 3rd, HONLIV HEALTH spent HKD 6.2967 million to repurchase 3 million sharesZhitong·Feb 3, 2025 at 11:23 AM099060.00%